期刊文献+

我院2006-2010年抗菌药物用量与大肠埃希菌耐药的相关性分析 被引量:13

Correlation of Antibacterials Consumption and Drug Resistance of Escherichia coli in Our Hospital from 2006 to 2010
原文传递
导出
摘要 目的:了解我院大肠埃希菌耐药性的现状和变迁,探讨其发展与抗菌药物用量之间的关系,为抗菌药物管理提供依据。方法:采用回顾性调查方法,计算13种抗菌药物平均每日每百张床位所消耗的用药频度(DDDs)及同期大肠埃希菌的耐药率,用SPSS17.0统计软件对抗菌药物用量与耐药率进行相关性分析。结果:高档次的抗菌药物用量逐年增长,低档次的抗菌药物用量逐年缩减。大肠埃希菌对多种抗菌药物呈广泛耐药,且逐年增长。庆大霉素、氨苄西林、哌拉西林/舒巴坦、头孢唑林、头孢呋辛、头孢西丁、头孢曲松、头孢他啶、环丙沙星、左氧氟沙星、亚胺培南/西司他丁的用量与大肠埃希菌对阿米卡星、庆大霉素、氨苄西林、头孢唑林、头孢呋辛、头孢西丁、头孢噻肟、头孢他啶的耐药率呈不同程度的相关性。结论:大肠埃希菌对多种抗菌药物耐药率高,抗菌药物使用量与大肠埃希菌耐药水平之间存在相关性;应加强细菌耐药监测和抗菌药物临床应用管理。 OBJECTIVE:To explore the change of drug resistance of Escherichia coli and explore the relation between its development and antibacterials consumption to provide reference for antibacterials management. METHODS: Retrospective review was used to calculate the DDDs of 13 kinds of antibacterialsper 100 persons per day and resistant rate of Escherichia coli. The correlation of antibacterials consumption and drug resistance was analyzed by SPSS 17.0 software. RESULTS: Consumption of expensive antibacterials increased year by year, contrary to ordinary ones. Drug resistance of Escherichia coli to various antibacterials also increased year by year. The consumptions of gentamycin, ampicillin, piperacillin/sulbactam, cefazolin, cefuroxime, cefoxitin, ceftriaxome, ceftazidime, ciprofloxacin, levofloxacin and imipenem/cilastin were related to the drug resistance of Escherichia coli to amikacin, gentamycin, ampicillin, cefazolin, cefuroxime, cefoxitin, cefotaxime and ceftazidime in varying degree. CONCLUSION: High resistance rate has been found in Escherichia coli to various antibacterials. Antibacterials consumption is related to drug resistance of Escherichia coli.
出处 《中国药房》 CAS CSCD 北大核心 2011年第26期2456-2458,共3页 China Pharmacy
关键词 大肠埃希菌 抗菌药物 耐药性 相关性 Escherichia coli Antibacterials Drug resistance Correlation
  • 相关文献

参考文献10

二级参考文献86

共引文献493

同被引文献87

  • 1卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 2袁天烁.大环内酯类抗生素的研究与应用进展[J].现代中西医结合杂志,2005,14(19):2620-2621. 被引量:19
  • 3葛涵,沈舜义.大环内酯类抗生素研究进展[J].世界临床药物,2007,28(6):376-380. 被引量:28
  • 4Rodríguez-Ba o J,Pascual A.Clinical significance of ex-tended-spectrum beta-lactemases[J].Expert Review of An-ti-infective Theray,2008,6(5):671.
  • 5Johanson WG,Dever LL.Nosocomial pneumonia[J].In-tensive Care Med,2003,29(1):23.
  • 6Corbella X,Montero A,Pujol M,et al.Emergence and rapid spread of earbapenem resistance during a large and sustained hospital outbreak of multiresistant Acineto-baeter baumannii[J].Clin Microbiol,2000,38(11):4086.
  • 7Bronzwaer SL,Cars O,Bucholz U,et al.A European study on the relationship between antimicrobial use and antimicrobial resistance[J].Emerg Infect Dis,2002;8:278-282.
  • 8Biswas T, Das M, Mondal R, et al. Prevalence of ESBL producing Escherichia Colt and Klebsiella species with their co-resistance pattern to antimicrobials [ J]. Mymensingh Med J, 2013,22(2) :377-384.
  • 9Ababneh M, Harpe S, Oinonen M, et al. Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: impli- cations for antitnicrobial stewardship [ J]. Infect Control Hosp Epidemio1,2012,33 (6):594-601.
  • 10Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria ( VRE and CPE ) [ J ]. Antimicrob Resist Infect Control,2012,1(1) :9.

引证文献13

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部